[Clinical Characteristics and Survival Analysis of Patients with Plasma Cell Leukemia].

Wang, Shi-Fang; Qin, Xiao-Qi; Guo, Qiao-Hua; Wang, Jing-Yu; Ma, Yan-Ping

Wang, Shi-Fang; Qin, Xiao-Qi; Guo, Qiao-Hua; Wang, Jing-Yu; Ma, Yan-Ping.

Afiliación

Wang SF; The Second Clinical Medical College of Shanxi Medical University,Taiyuan 030000, Shanxi Province, China.
Qin XQ; Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030000, Shanxi Province, China.
Guo QH; The Second Clinical Medical College of Shanxi Medical University,Taiyuan 030000, Shanxi Province, China.
Wang JY; The Second Clinical Medical College of Shanxi Medical University,Taiyuan 030000, Shanxi Province, China.
Ma YP; Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030000, Shanxi Province, China.E-mail: myanp18@163.com.

Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 31(3): 693-698, 2023 Jun.

Article en Zh | MEDLINE | ID: mdl-37356928

Asunto(s)

Leucemia de Células Plasmáticas; Masculino; Femenino; Humanos; Leucemia de Células Plasmáticas/diagnóstico; Estudios Retrospectivos; Bortezomib/uso terapéutico; Pronóstico; Análisis de Supervivencia

Palabras clave

bortezomib; clinical characteristics; plasma cell leukemia; prognosis; treatment response

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia de Células Plasmáticas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google